Cours suspendu

Autres langues Avidity Biosciences, Inc.

Actions

RNA

US05370A1088

Produits pharmaceutiques

Marché Fermé - Nasdaq 22:00:00 26/02/2026			Varia. 5j.	Varia. 1 janv.
72,82 ^USD	+0,03%		-.--%	+0,96%

29/09	Le secteur pharmaceutique mise davantage sur l’IA pour réduire les coûts et les délais	RE
21/09	Le secteur pharmaceutique mise sur l'IA pour réduire ses coûts et ses délais	RE

Autres langues

29/09	Pharma sector doubles down on AI to slash costs, timelines
21/09	Pharma sector doubles down on AI to slash costs, timelines
16/09	Pharma sector doubles down on AI to slash costs, timelines
20/08	Pharma sector doubles down on AI amid hopes of slashing costs, timelines
13/08	Atrium Therapeutics Earns Another $15 Million Milestone Payment From Bristol Myers Squibb
14/07	Atrium Therapeutics Says FDA Clears Phase 1/2 Trial of ATR 1072 in PRKAG2 Syndrome
20/05	Pharma sector doubles down on AI amid hopes of slashing costs, timelines
23/04	Atrium Therapeutics Earns $15 Million Milestone From Bristol Myers Squibb
14/04	Pharma sector doubles down on AI amid hopes of slashing costs, timelines
17/03	Novartis Raises $11 Billion to Fund Avidity Biosciences Deal
16/03	Novartis Unit Files to Sell Notes to Repay Loan for Avidity Biosciences Acquisition
16/03	Novartis Issues Debt Offering to Help Fund $12 Billion Acquisition of Avidity Biosciences
03/03	Avidity Biosciences, Inc.(NasdaqGM:RNAM) dropped from S&P Global BMI Index
03/03	Avidity Biosciences, Inc.(NasdaqGM:RNAM) dropped from S&P Biotechnology Select Industry Index
03/03	Avidity Biosciences, Inc.(NasdaqGM:RNAM) dropped from S&P TMI Index
02/03	Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies
02/03	Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy
02/03	Avidity Biosciences, Inc.(NasdaqGM:RNAM) dropped from Russell Small Cap Comp Growth Benchmark
02/03	Avidity Biosciences, Inc.(NasdaqGM:RNAM) dropped from Russell 3000E Growth Benchmark
02/03	Avidity Biosciences, Inc.(NasdaqGM:RNAM) dropped from Russell 3000 Growth Benchmark
02/03	Avidity Biosciences, Inc.(NasdaqGM:RNAM) dropped from Russell 2500 Growth Benchmark
02/03	Avidity Biosciences, Inc.(NasdaqGM:RNAM) dropped from Russell 2000 Growth Benchmark
02/03	Avidity Biosciences, Inc.(NasdaqGM:RNAM) dropped from Russell 2500 Value-Dynamic Index
02/03	Avidity Biosciences, Inc.(NasdaqGM:RNAM) dropped from Russell 2500 Growth-Dynamic Index
02/03	Avidity Biosciences, Inc.(NasdaqGM:RNAM) dropped from Russell 2000 Value-Dynamic Index